Literature DB >> 24997154

Genomic complexity and IGHV mutational status are key predictors of outcome of chronic lymphocytic leukemia patients with TP53 disruption.

Julio Delgado1, Itziar Salaverria2, Tycho Baumann3, Alejandra Martínez-Trillos2, Eriong Lee2, Laura Jiménez2, Alba Navarro2, Cristina Royo2, Rodrigo Santacruz3, Cristina López2, Angel R Payer4, Enrique Colado4, Marcos González5, Lluís Armengol6, Dolors Colomer2, Magda Pinyol2, Neus Villamor2, Marta Aymerich2, Ana Carrió2, Dolors Costa2, Guillem Clot2, Eva Giné3, Armando López-Guillermo3, Elías Campo2, Sílvia Beà2.   

Abstract

Entities:  

Keywords:  17p deletion; CLL; CN-arrays; IGHV; TP53; genome complexity

Mesh:

Substances:

Year:  2014        PMID: 24997154      PMCID: PMC4222465          DOI: 10.3324/haematol.2014.108365

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  15 in total

1.  Genome-wide DNA analysis identifies recurrent imbalances predicting outcome in chronic lymphocytic leukaemia with 17p deletion.

Authors:  Francesco Forconi; Andrea Rinaldi; Ivo Kwee; Elisa Sozzi; Donatella Raspadori; Paola M V Rancoita; Marta Scandurra; Davide Rossi; Clara Deambrogi; Daniela Capello; Emanuele Zucca; Daniela Marconi; Riccardo Bomben; Valter Gattei; Francesco Lauria; Gianluca Gaidano; Francesco Bertoni
Journal:  Br J Haematol       Date:  2008-08-24       Impact factor: 6.998

2.  Array-based genomic screening at diagnosis and during follow-up in chronic lymphocytic leukemia.

Authors:  Rebeqa Gunnarsson; Larry Mansouri; Anders Isaksson; Hanna Göransson; Nicola Cahill; Mattias Jansson; Markus Rasmussen; Jeanette Lundin; Stefan Norin; Anne Mette Buhl; Karin Ekström Smedby; Henrik Hjalgrim; Karin Karlsson; Jesper Jurlander; Christian Geisler; Gunnar Juliusson; Richard Rosenquist
Journal:  Haematologica       Date:  2011-05-05       Impact factor: 9.941

3.  Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia.

Authors:  Xose S Puente; Magda Pinyol; Víctor Quesada; Laura Conde; Gonzalo R Ordóñez; Neus Villamor; Georgia Escaramis; Pedro Jares; Sílvia Beà; Marcos González-Díaz; Laia Bassaganyas; Tycho Baumann; Manel Juan; Mónica López-Guerra; Dolors Colomer; José M C Tubío; Cristina López; Alba Navarro; Cristian Tornador; Marta Aymerich; María Rozman; Jesús M Hernández; Diana A Puente; José M P Freije; Gloria Velasco; Ana Gutiérrez-Fernández; Dolors Costa; Anna Carrió; Sara Guijarro; Anna Enjuanes; Lluís Hernández; Jordi Yagüe; Pilar Nicolás; Carlos M Romeo-Casabona; Heinz Himmelbauer; Ester Castillo; Juliane C Dohm; Silvia de Sanjosé; Miguel A Piris; Enrique de Alava; Jesús San Miguel; Romina Royo; Josep L Gelpí; David Torrents; Modesto Orozco; David G Pisano; Alfonso Valencia; Roderic Guigó; Mónica Bayés; Simon Heath; Marta Gut; Peter Klatt; John Marshall; Keiran Raine; Lucy A Stebbings; P Andrew Futreal; Michael R Stratton; Peter J Campbell; Ivo Gut; Armando López-Guillermo; Xavier Estivill; Emili Montserrat; Carlos López-Otín; Elías Campo
Journal:  Nature       Date:  2011-06-05       Impact factor: 49.962

Review 4.  ERIC recommendations on TP53 mutation analysis in chronic lymphocytic leukemia.

Authors:  S Pospisilova; D Gonzalez; J Malcikova; M Trbusek; D Rossi; A P Kater; F Cymbalista; B Eichhorst; M Hallek; H Döhner; P Hillmen; M van Oers; J Gribben; P Ghia; E Montserrat; S Stilgenbauer; T Zenz
Journal:  Leukemia       Date:  2012-02-02       Impact factor: 11.528

5.  Genomic aberrations and survival in chronic lymphocytic leukemia.

Authors:  H Döhner; S Stilgenbauer; A Benner; E Leupolt; A Kröber; L Bullinger; K Döhner; M Bentz; P Lichter
Journal:  N Engl J Med       Date:  2000-12-28       Impact factor: 91.245

6.  Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities.

Authors:  G Juliusson; D G Oscier; M Fitchett; F M Ross; G Stockdill; M J Mackie; A C Parker; G L Castoldi; A Guneo; S Knuutila; E Elonen; G Gahrton
Journal:  N Engl J Med       Date:  1990-09-13       Impact factor: 91.245

7.  SF3B1 and other novel cancer genes in chronic lymphocytic leukemia.

Authors:  Lili Wang; Michael S Lawrence; Youzhong Wan; Petar Stojanov; Carrie Sougnez; Kristen Stevenson; Lillian Werner; Andrey Sivachenko; David S DeLuca; Li Zhang; Wandi Zhang; Alexander R Vartanov; Stacey M Fernandes; Natalie R Goldstein; Eric G Folco; Kristian Cibulskis; Bethany Tesar; Quinlan L Sievers; Erica Shefler; Stacey Gabriel; Nir Hacohen; Robin Reed; Matthew Meyerson; Todd R Golub; Eric S Lander; Donna Neuberg; Jennifer R Brown; Gad Getz; Catherine J Wu
Journal:  N Engl J Med       Date:  2011-12-12       Impact factor: 91.245

8.  Chronic lymphocytic leukaemia with 17p deletion: a retrospective analysis of prognostic factors and therapy results.

Authors:  Julio Delgado; Blanca Espinet; Ana C Oliveira; Pau Abrisqueta; Javier de la Serna; Rosa Collado; Javier Loscertales; Montserrat Lopez; Jose A Hernandez-Rivas; Christelle Ferra; Angel Ramirez; Josep M Roncero; Cristina Lopez; Anna Aventin; Anna Puiggros; Eugenia Abella; Felix Carbonell; Dolors Costa; Anna Carrio; Marcos Gonzalez
Journal:  Br J Haematol       Date:  2012-01-09       Impact factor: 6.998

9.  De novo deletion 17p13.1 chronic lymphocytic leukemia shows significant clinical heterogeneity: the M. D. Anderson and Mayo Clinic experience.

Authors:  Constantine S Tam; Tait D Shanafelt; William G Wierda; Lynne V Abruzzo; Daniel L Van Dyke; Susan O'Brien; Alessandra Ferrajoli; Susan A Lerner; Alice Lynn; Neil E Kay; Michael J Keating
Journal:  Blood       Date:  2009-05-04       Impact factor: 22.113

10.  Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial.

Authors:  D Catovsky; S Richards; E Matutes; D Oscier; Mjs Dyer; R F Bezares; A R Pettitt; T Hamblin; D W Milligan; J A Child; M S Hamilton; C E Dearden; A G Smith; A G Bosanquet; Z Davis; V Brito-Babapulle; M Else; R Wade; P Hillmen
Journal:  Lancet       Date:  2007-07-21       Impact factor: 79.321

View more
  17 in total

1.  Cross-platform assessment of genomic imbalance confirms the clinical relevance of genomic complexity and reveals loci with potential pathogenic roles in diffuse large B-cell lymphoma.

Authors:  Lizalynn M Dias; Venkata Thodima; Julia Friedman; Charles Ma; Asha Guttapalli; Geetu Mendiratta; Imran N Siddiqi; Sergei Syrbu; R S K Chaganti; Jane Houldsworth
Journal:  Leuk Lymphoma       Date:  2015-11-16

2.  Chronic lymphocytic leukemia: from molecular pathogenesis to novel therapeutic strategies.

Authors:  Julio Delgado; Ferran Nadeu; Dolors Colomer; Elias Campo
Journal:  Haematologica       Date:  2020-07-02       Impact factor: 9.941

3.  Refined karyotype-based prognostic stratification of chronic lymphocytic leukemia with a low- and very-low-risk genetic profile.

Authors:  I Del Giudice; G M Rigolin; S Raponi; L Cafforio; C Ilari; J Wang; M Bordyuh; A Piciocchi; M Marinelli; M Nanni; S Tavolaro; M Filetti; A Bardi; E Tammiso; E Volta; M Negrini; E Saccenti; F R Mauro; D Rossi; G Gaidano; A Guarini; R Rabadan; A Cuneo; R Foà
Journal:  Leukemia       Date:  2017-09-19       Impact factor: 11.528

4.  Survival of Del17p CLL Depends on Genomic Complexity and Somatic Mutation.

Authors:  Sunita R Setlur; Jennifer R Brown; Lijian Yu; Haesook T Kim; Siddha Kasar; Parul Benien; Wei Du; Kevin Hoang; Andrew Aw; Bethany Tesar; Reina Improgo; Stacey Fernandes; Saranya Radhakrishnan; Josephine Klitgaard; Charles Lee; Gad Getz
Journal:  Clin Cancer Res       Date:  2016-08-08       Impact factor: 12.531

5.  Activated Allogeneic NK Cells Preferentially Kill Poor Prognosis B-Cell Chronic Lymphocytic Leukemia Cells.

Authors:  Diego Sánchez-Martínez; Pilar M Lanuza; Natalia Gómez; Aura Muntasell; Elisa Cisneros; Manuela Moraru; Gemma Azaceta; Alberto Anel; Luis Martínez-Lostao; Martin Villalba; Luis Palomera; Carlos Vilches; José A García Marco; Julián Pardo
Journal:  Front Immunol       Date:  2016-10-27       Impact factor: 7.561

Review 6.  Identifying High-Risk Chronic Lymphocytic Leukemia: A Pathogenesis-Oriented Appraisal of Prognostic and Predictive Factors in Patients Treated with Chemotherapy with or without Immunotherapy.

Authors:  Sara Martinelli; Antonio Cuneo; Luca Formigaro; Maurizio Cavallari; Enrico Lista; Francesca Maria Quaglia; Maria Ciccone; Antonella Bardi; Eleonora Volta; Elisa Tammiso; Elena Saccenti; Olga Sofritti; Giulia Daghia; Massimo Negrini; Melissa Dabusti; Paolo Tomasi; Sabrina Moretti; Francesco Cavazzini; Gian Matteo Rigolin
Journal:  Mediterr J Hematol Infect Dis       Date:  2016-10-15       Impact factor: 2.576

7.  Karyotypic complexity rather than chromosome 8 abnormalities aggravates the outcome of chronic lymphocytic leukemia patients with TP53 aberrations.

Authors:  Gonzalo Blanco; Anna Puiggros; Panagiotis Baliakas; Anastasia Athanasiadou; MªDolores García-Malo; Rosa Collado; Aliki Xochelli; María Rodríguez-Rivera; Margarita Ortega; Mª José Calasanz; Elisa Luño; MªTeresa Vargas; Javier Grau; Carolina Martínez-Laperche; Alberto Valiente; José Cervera; Achilles Anagnostopoulos; Eva Gimeno; Eugènia Abella; Evangelia Stalika; Jesús Mª Hernández-Rivas; Francisco José Ortuño; Diego Robles; Ana Ferrer; David Ivars; Marcos González; Francesc Bosch; Pau Abrisqueta; Kostas Stamatopoulos; Blanca Espinet
Journal:  Oncotarget       Date:  2016-12-06

8.  A gene signature that distinguishes conventional and leukemic nonnodal mantle cell lymphoma helps predict outcome.

Authors:  Guillem Clot; Pedro Jares; Eva Giné; Alba Navarro; Cristina Royo; Magda Pinyol; David Martín-Garcia; Santiago Demajo; Blanca Espinet; Antonio Salar; Ana Ferrer; Ana Muntañola; Marta Aymerich; Hilka Rauert-Wunderlich; Elaine S Jaffe; Joseph M Connors; Randy D Gascoyne; Jan Delabie; Armando López-Guillermo; German Ott; George W Wright; Louis M Staudt; Andreas Rosenwald; David W Scott; Lisa M Rimsza; Sílvia Beà; Elías Campo
Journal:  Blood       Date:  2018-05-16       Impact factor: 25.476

9.  Prognostic models for newly-diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta-analysis.

Authors:  Nina Kreuzberger; Johanna Aag Damen; Marialena Trivella; Lise J Estcourt; Angela Aldin; Lisa Umlauff; Maria Dla Vazquez-Montes; Robert Wolff; Karel Gm Moons; Ina Monsef; Farid Foroutan; Karl-Anton Kreuzer; Nicole Skoetz
Journal:  Cochrane Database Syst Rev       Date:  2020-07-31

10.  Detection of chromothripsis-like patterns with a custom array platform for chronic lymphocytic leukemia.

Authors:  Itziar Salaverria; David Martín-Garcia; Cristina López; Guillem Clot; Manel García-Aragonés; Alba Navarro; Julio Delgado; Tycho Baumann; Magda Pinyol; Idoia Martin-Guerrero; Ana Carrió; Dolors Costa; Ana C Queirós; Sandrine Jayne; Marta Aymerich; Neus Villamor; Dolors Colomer; Marcos González; Armando López-Guillermo; Elías Campo; Martin J S Dyer; Reiner Siebert; Lluís Armengol; Sílvia Beà
Journal:  Genes Chromosomes Cancer       Date:  2015-08-25       Impact factor: 5.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.